Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

NCT04706013 is registered in ClinicalTrials.gov with Medicure as lead sponsor.

NCT NCT04706013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04706013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Lead sponsor
Medicure
Phase
Phase 3
Overall status
Recruiting
Start date
February 16, 2024
Completion date
November 30, 2026
Enrollment
15 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pyridox(am)ine 5'-phosphate oxidase deficiency